Live Health News

Global Health & Medical Updates

Curated from world health organizations, leading research institutes, and accredited publishers.

GLP-1 Medicines Linked to Lower Diabetes Progression and Cardiovascular Risks in People...
Diabetes
Original
HealthGuru
Nov 3, 2026

GLP-1 Medicines Linked to Lower Diabetes Progression and Cardiovascular Risks in People With Prediabetes

Preliminary research involving more than 250,000 adults with prediabetes and obesity found that people taking GLP-1 medicines were more likely to return to normal blood glucose levels and had lower reported risks of progressing to type 2 diabetes than those taking metformin. The findings are being presented at the American Heart Association Scientific Sessions 2026.

System Admin
Read Full
Eli Lilly Reports Promising Phase III Results for Experimental Diabetes and Weight-Loss...
Diabetes
Original
HealthGuru
Oct 29, 2026

Eli Lilly Reports Promising Phase III Results for Experimental Diabetes and Weight-Loss Drug Retatrutide

On 28 October 2026, reports described Eli Lilly's announcement that its experimental medicine retatrutide outperformed semaglutide, the active ingredient in Ozempic, in a Phase III trial involving people with type 2 diabetes. The results have attracted attention because of the continuing search for more effective treatments for diabetes and obesity. Retatrutide remains an investigational medicine, and reported trial findings should not be interpreted as proof that it is approved or suitable for routine treatment.

System Admin
Read Full
New Review Examines Benefits and Safety Risks of Popular GLP-1 Medicines
Diabetes
Original
HealthGuru
Oct 27, 2026

New Review Examines Benefits and Safety Risks of Popular GLP-1 Medicines

A review of GLP-1 receptor agonists published in the medical news cycle on 26 October 2026 has drawn attention to the benefits and potential risks of this class of medicines. These treatments can support blood sugar control and weight management in appropriate patients, but concerns involving pancreatitis and other adverse effects underline the need for individual medical assessment and monitoring.

System Admin
Read Full
Access to Primary Care Resources May Influence Outcomes for People With Type 2 Diabetes
Diabetes
Original
HealthGuru
Oct 16, 2026

Access to Primary Care Resources May Influence Outcomes for People With Type 2 Diabetes

Research reported on 15 October 2026 examined the relationship between primary care provider resources and health outcomes among people with type 2 diabetes. The findings highlight the importance of accessible primary care, regular monitoring, and continuity of treatment for a disease that can cause serious complications when blood glucose remains poorly controlled. The report focuses on healthcare delivery rather than establishing a new diabetes medication or treatment.

System Admin
Read Full
High-Fiber Diet Shows Promise for Improving Blood Sugar and Weight in a Clinical Trial
Diabetes
Original
HealthGuru
Oct 15, 2026

High-Fiber Diet Shows Promise for Improving Blood Sugar and Weight in a Clinical Trial

Recent medical research coverage highlighted a trial comparing a high-fiber dietary intervention with metformin for blood sugar and weight outcomes. The findings suggest that dietary composition may play an important role in metabolic management. However, the available summary does not provide enough verified information about the trial's participants, treatment duration, effect sizes, or full statistical results to conclude that a high-fiber diet is generally superior to metformin.

System Admin
Read Full
Diet and Structured Exercise Help More Than Half of Participants With Early-Onset Type...
Diabetes
Original
HealthGuru
Oct 14, 2026

Diet and Structured Exercise Help More Than Half of Participants With Early-Onset Type 2 Diabetes Achieve Remission

Research from the RESET for Remission trial found that 27 of 50 participants receiving a low-energy diet and structured exercise achieved type 2 diabetes remission after 24 weeks, compared with 2 of 46 participants receiving usual care. The intervention combined a supervised low-calorie diet with aerobic and resistance exercise. The findings suggest that carefully supervised lifestyle interventions may help selected younger adults with type 2 diabetes improve metabolic health and reduce their reliance on glucose-lowering medication.

System Admin
Read Full

Health & Medical Information Disclaimer

The health news, articles, research summaries, and videos aggregated on HealthGhuru are provided for educational and informational purposes only. Content should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified physician or healthcare provider regarding any health condition or dietary changes.